Active, not recruitingNCT07022886

INCIDENCE, PREVALENCE AND OVERALL RISK OF ESOPHAGEAL CANCER IN ACHALASIA: A PROPENSITY-MATCHED POPULATION-BASED STUDY FROM A LARGE MULTICENTER DATABASE

Studying Idiopathic achalasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IRCCS San Raffaele
Principal Investigator
Albert Jan Bredenoord, MD, PhD, Prof
Department of Gastroenterology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands
Intervention
achalasia treatments(procedure)
Enrollment
47000 enrolled
Eligibility
All sexes
Timeline
2025 – 2025

Study locations (1)

Collaborators

TriNetX, LLC · Vita-Salute San Raffaele University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07022886 on ClinicalTrials.gov

Other trials for Idiopathic achalasia

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic achalasia →

← Back to all trials